Hong Kong IPOs explode in first half as China Inc. abandons New York
Hong Kong listings by 44 companies raised $13.6 billion in the first six months of 2025, accounting for a quarter of the world’s total IPO fundraising Key Takeaways: Hong Kong…
BRIEF: EPWK ends flat in Nasdaq trading debut
Gig worker crowdsourcing platform operator EPWK Holdings Inc. (EPWK.US) made a muted trading debut on Thursday, closing up a slight 0.24% at $4.11 in its first trading day on the…
BRIEF: Ascentage Pharma prices U.S. IPO at 20% discount, to raise up to $130 million
Biopharmaceutical company Ascentage Pharma Group International (6855.HK) announced Friday that it will offer 7.325 million American Depositary Shares (ADS) in its upcoming U.S. listing at an issue price of $17.25…
BRIEF: Ascentage Pharma gets Chinese regulatory nod for U.S. listing
Biopharmaceutical company Ascentage Pharma Group International (6855.HK) received a listing approval notice from the China Securities Regulatory Commission (CSRC) on Monday, a necessary step before it can make an overseas…
Is shunned Shein the future for blockbuster China IPOs?
The fast fashion sensation’s plan for a London listing may be coming unglued, after it abandoned a New York IPO plan for similar politically motivated reasons Key Takeaways: Shein may…
FAST NEWS: Bilibili’s losses narrow on improving efficiency
The Latest: Video site Bilibili Inc. (9626.HK, BILI.US) on Thursday reported its revenue rose 3% year-on-year to 6.3 billion yuan ($876 million) in last year’s fourth quarter, while its loss narrowed 13% to 1.3 billion…
With no cure in sight, drugs firm LianBio begins exit strategy
The biotech, which obtained rights to novel drugs for use in the Chinese market, has announced a plan to wind up its business and delist from the Nasdaq just four…
